CR8957A - stable liquid formulations of plasmid DNA - Google Patents

stable liquid formulations of plasmid DNA


Publication number
CR8957A CR8957A CR8957A CR8957A CR 8957 A CR8957 A CR 8957A CR 8957 A CR8957 A CR 8957A CR 8957 A CR8957 A CR 8957A CR 8957 A CR8957 A CR 8957A
Costa Rica
Prior art keywords
plasmid dna
liquid formulations
stable liquid
Prior art date
Application number
Other languages
Spanish (es)
Blanche Francis
Couder Michel
Maestrali Nicolas
Gaillac David
Guillemin Thierry
Original Assignee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US50346403P priority Critical
Priority to PCT/EP2004/011437 priority patent/WO2005026331A2/en
Priority to PCT/EP2005/005213 priority patent/WO2005100542A1/en
Application filed by Centelion filed Critical Centelion
Publication of CR8957A publication Critical patent/CR8957A/en



Esta invencion se refiere a formulaciones liquidas de ADN plasmidico que son estables y en las que el plasmido permanece sin degradarse de 4 grados centigrados hasta temperatura ambiente durante largos periodos de tiempo y asi son utiles para el almacenamiento del ADN plasmidico, tales como vacunas de ADN y terapia genica. This invention relates to liquid formulations of plasmid DNA that are stable and where the plasmid remains undegraded 4 degrees Celsius to room temperature for long periods of time and are thus useful for storage of plasmid DNA, such as DNA vaccines and gene therapy.
CR8957A 2003-09-17 2007-03-05 stable liquid formulations of plasmid DNA CR8957A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US50346403P true 2003-09-17 2003-09-17
PCT/EP2004/011437 WO2005026331A2 (en) 2003-09-17 2004-09-17 Method of preparation of pharmaceutically grade plasmid dna
PCT/EP2005/005213 WO2005100542A1 (en) 2004-04-19 2005-04-19 Method for purifying plasmid dna

Publications (1)

Publication Number Publication Date
CR8957A true CR8957A (en) 2007-10-01



Family Applications (1)

Application Number Title Priority Date Filing Date
CR8957A CR8957A (en) 2003-09-17 2007-03-05 stable liquid formulations of plasmid DNA

Country Status (3)

Country Link
CR (1) CR8957A (en)
SI (1) SI1664277T1 (en)
ZA (1) ZA200602244B (en)

Also Published As

Publication number Publication date
SI1664277T1 (en) 2012-02-29
ZA200602244B (en) 2007-06-27

Similar Documents

Publication Publication Date Title
CR8363A (en) Substituted pyrimidines sulfoximine as Cdk inhibitors and / or vegf, their preparation and their use as medicaments
CR8753A (en) Tetraaza derivatives [e] azulene and its Analogs
NO20084738L (en) Compounds and methods feeder for modulating expression of PCSK9
MY140539A (en) 1-amino 1h-imidazoquinolines
HN2006019066A (en) "(S) -n-methylnaltrexone"
ECSP034559A (en) New non-imidazole compounds
PA8557501A1 (en) Benzamide, or heteroaryl and reverse amides
CY1115684T1 (en) The fungicidal mixture containing substituted anilide 1-methylpyrazole-4-ylokarvonikou ACID
CO6351786A2 (en) Inkibidores p38 map kinase
PA8592201A1 (en) Novel aromatic fluoroglicosidos, medicaments containing these compounds and their uses
GT200500375A (en) Piperidine derivatives and their use as antiinflammatory agents
AR023465A1 (en) substituted azoles
GT200600193A (en) Imidazoquinolines as lipid kinase inhibitors
HN2005035605A (en) Analogs of rapamycin and the uses thereof in the treatment of neurological disorders, proliferative and inflammatory
CR9459A (en) Benzodioxan and benzodioxolane derivatives and uses thereof
AR024318A1 (en) Nucleic acid molecules wheat, transgenic plant cells and plants and the use thereof for the production of modified starch.
DOP2010000084A (en) The uracil derivative or thymine for treatment of hepatitis c
ECSP077421A (en) Compounds and compositions as inhibitors of the activity of cannabinoid receptor 1
CY1116285T1 (en) Anasyndyasmenes n-glykozyliomenes PROTEINS from prokaryotic
MX2008001931A (en) Xanthine derivatives as selective hm74a agonists.
ES2032899T3 (en) cosmetic agent for external application and usage.
BRPI0615250A2 (en) 1h-imidazopyridines replaced by hidràxi, pharmaceutical composiÇço containing the same, and their uses
NO333378B1 (en) Human anti-TNF antibody, isolated nucleic acid molecule, recombinant vector, host cell and composition
NO20051451L (en) Pyrimidine derivatives and their use as CB2 modulators
AR013845A1 (en) Gene synthesis method

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)